SHIONOGI & CO LTD (SGIOF:OTCMKTS)

$17.45 -0.1 (-0.5698%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 55

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SHIONOGI & CO LTD (SGIOF:OTCMKTS) News Sources

D-Wave CEO on quantum computing's ChatGPT moment, Nvidia, & more

14-04-2026

yahoo.com

Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates

07-05-2026

yahoo.com

Shionogi (TSE:4507) Valuation Check As XOCOVA Wins First US FDA Approval For COVID 19 Post Exposure Prophylaxis

10-06-2026

yahoo.com

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

22-06-2026

yahoo.com

FDA Accepts Shionogi’s sNDA for Fetroja® (cefiderocol) for Use in Pediatric Patients with Serious Infections Caused by Susceptible Gram-negative Bacteria

16-07-2026

yahoo.com

Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Report Q1 Results: Wall Street Expects Earnings Growth

20-07-2026

yahoo.com

ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

21-07-2026

yahoo.com

United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 Release

22-07-2026

yahoo.com

Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026

29-07-2026

yahoo.com

Shionogi Recognizes the Four-Year Anniversary of RADICAVA ORS® (edaravone) for Treatment of ALS

30-07-2026

yahoo.com

SHIONOGI & CO LTD (SGIOF:OTCMKTS) Sentiment Trend

0 25 50 75 100 74 2 60 66 69 5 82 64 61 64 14-04-2026 07-05-2026 10-06-2026 22-06-2026 16-07-2026 20-07-2026 21-07-2026 22-07-2026 29-07-2026 30-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SHIONOGI & CO LTD (SGIOF:OTCMKTS) FAQs

toggle

What is the current price of SHIONOGI & CO LTD (SGIOF:OTCMKTS)?

The current price of SHIONOGI & CO LTD (SGIOF:OTCMKTS) is $17.45.


toggle

SHIONOGI & CO LTD (SGIOF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of SHIONOGI & CO LTD (SGIOF:OTCMKTS) since the previous trading day is $-0.1.


toggle

SHIONOGI & CO LTD (SGIOF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of SHIONOGI & CO LTD (SGIOF:OTCMKTS) since the previous trading day is -0.5698%.


toggle

What is the most recent average sentiment score for SHIONOGI & CO LTD (SGIOF:OTCMKTS)?

The most recent average sentiment score for SHIONOGI & CO LTD (SGIOF:OTCMKTS) is 55 out of 100.


toggle

What is the most recent average sentiment for SHIONOGI & CO LTD (SGIOF:OTCMKTS)?

The most recent sentiment for SHIONOGI & CO LTD (SGIOF:OTCMKTS) is .


SEC-8K** Filing Available For SHIONOGI & CO LTD (SGIOF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.